To Win at All Costs

To Win at All Costs

Meryl Nass   April 14, 2026   Government, Law   

Brownstone Journal

To Win at All Costs

Bayer bought Monsanto in 2018 for $63 billion —a few months before Monsanto lost its first liability case for causing non-Hodgkins lymphoma. I was not a close observer of the case, but the win seemed to hinge on documents obtained during discovery that revealed Monsanto knew a great deal about the injuries its product caused but deliberately hid those findings.

Once there was a win—and the jury awarded the plaintiff with non-Hodgkin’s lymphoma hundreds of millions, later reduced—the bandwagon effect began, with other lawyers seeking plaintiffs to sue Monsanto. Eventually over 100,000 plaintiffs were suing Monsanto/Bayer for cancers related to glyphosate, the so-called active ingredient in Roundup. There are other ingredients that are probably toxic too, but they were not at issue. Most plaintiffs were homeowners. Bayer then removed glyphosate from Roundup, producing a new formulation for homeowners. 

Still, there were more and more cases and more and more wins in state courts due to Monsanto/Bayer’s failure to warn of a cancer risk. Then Monsanto settled about 50,000 of the cases.

The settlements and the big losses have cost Bayer $10 billion so far.

Not only did Bayer pay out a King’s ransom, but its stock price tanked. Desperate times call for desperate measures. Bayer, a German company, hired a Texan, Bill Anderson, as CEO to come to its aid. CEO Anderson’s career hinged on stanching Bayer’s bleed. He initiated a very expensive series of legal and political strategies in the hopes that one would be successful. He also formed a new agricultural industry lobby group with a huge advertising budget.

CEO Anderson got the Bayer board to agree to setting aside around $17 billion for this problem. With $10 billion already spent (the same figure reported 5 months ago) that left him with about $7.6 billion to deal with the 67,000 pending cases and to end the litigation for good.

I discussed the six different tracks Anderson pursued to make this problem go away in this piece. One of those tracks was getting Congress to pass a bill rider that would provide a liability shield by forbidding the EPA from making label changes unless a tedious, years-long process had been undertaken. 

The bill rider got a lot of pushback from my readers and many other constitutents during July-September 2025, when it passed the EPA’s Appropriations committee on a voice vote, thereby shielding individual members from having to own up to their vote. Apparently it was not going to go through the whole House easily (lots of political capital would have been expended by every member voting for it) and so far, the bill that included the pesticide rider has not been brought to a House vote. There was no companion bill in the Senate, another clue that Congressmembers did not want their fingerprints on this obvious giveaway to Big Pesticide and Bayer at the expense of citizens.

The five other tracks included:

• This request to the Supreme Court to rule on the issue, which failed to gain a Supreme Court hearing in 2022, was filed again early last April.
• Bills in about 20 state legislatures that would end state causes of action for pesticide injuries, which passed in GA and ND, failed in TN and many other states, and have not been decided in other states.
• Threats by Bayer to take glyphosate off the market, which would allegedly harm the agriculture industry, even though there are generic versions of glyphosate available, and allegedly raise food prices drastically. This track was accompanied by a big publicity campaign.
• Assertions by Bayer that it was developing 5 newer pesticides and would simply replace glyphosate with something better (and potentially more dangerous). If it kept swapping out pesticides as their harms became known, it could avoid having label warnings placed on them.
• Bayer hinted it could spin off part of the company, leaving all the liability in an underfunded spinoff that would not be able to pay claims.

Remember, Bayer has a very fat bank account. Both Bayer and Monsanto are famous for sleazy corporate dealings and extremely serious product safety concerns. Bayer’s parent IG Farben even manufactured the Zyklon B gas used in concentration camps during World War II to kill millions, and used about 150,000 slave laborers. That’s how you make a real profit!

Bayer/Monsanto filed its request for a writ of certiorari (a request to take the case) with the Supreme Court on April 4, 2025. 

The Supreme Court invited the US Solicitor General to file a brief “expressing the views” of the US government on June 30, 2025. Only 1-2% of requests that it receives are actually taken up by the Court for a ruling. But by asking for a comment from the Administration, the chance that the Court will take the case is considerably higher.

Five months went by before there was a response. Then, on December 1, the Trump Solicitor General filed an amicus in response, asking the Supreme Court to take up the case on glyphosate injury, and furthermore, to rule in favor of Bayer. It is relevant, I think, that Bayer has garnered 5 amicus briefs in its favor, while the injured party, Durnell, has only his own brief. 

If the Supreme Court judges do what was asked of them by the US Solicitor General, all pesticides will receive a de facto liability shield–because the “failure to warn” of potential injuries on pesticide labels will no longer be an argument that can win a case. Labels (EPA-approved) will be assumed to be the final word on the subject of risk. This is the argument Bayer is making.

However, if the Court made a decision on this basis, it would seem to conform to the Chevron Doctrine, which the Supreme Court overturned 18 months ago. Chevron was a 40-year-old Supreme Court instruction to lower courts to not litigate questions that federal agencies had answered—instead, they should always give deference to the agency interpretation. Hopefully, the Court will recognize that it should NOT give agencies deference and instead allow controversies of science, medicine, or fact to be litigated in our courts.

So it is not clear what will happen, but there is a considerable chance the court will take the case, and if so, rule in Bayer’s favor.

Bayer’s share price rose 16% in the 10 days immediately after the Solicitor General’s amicus brief was filed.

If you would like to see Bayer gloating about the Solicitor General’s brief, read on. I just wonder what it cost them.

What can we do about it?

1. We need more amici briefs on the side of the plaintiff, Durnell, and against Bayer.
2. We need to put the Trump administration’s feet to the fire on this, get publicity, and make their choice very costly to them in terms of political capital, especially since Trump’s approval rating is around 42% now and the administration is trying to regain popularity.
3. The Court needs to learn how the Solicitor General’s brief “misspoke” about the IARC’s conclusion regarding possible vs probable danger of the carcinogenicity of glyphosate. I have asked associates to weigh in on this. It’s not exactly a fraud on the court, but it has a strong whiff of deceit, which the justices won’t like.
4. Please provide any other ideas that you have that can stop this travesty — we don’t need to add liability shields to other consumer products, now that we have seen what it did for vaccines.

Republished from the author’s Substack

Published under a Creative Commons Attribution 4.0 International License

For reprints, please set the canonical link back to the original Brownstone Institute Article and Author.

Author

Meryl Nass, MD, was an internal medicine physician in Maine until her license was suspended for treating COVID patients with HCQ and IVM and warning the public about the side effects of COVID vaccines.  She then founded Door to Freedom and now works as a writer and activist.

-------------------------

Source

https://brownstone.org/articles/to-win-at-all-costs/

The controversy surrounding Anthropic and its model, Claude

The controversy surrounding Anthropic and its model, Claude

----------------------------------------------------------

The controversy surrounding Anthropic and its model, Claude, has shifted dramatically recently. While earlier debates focused on its "Constitutional AI" being too preachy or restrictive, the current firestorm (as of early 2026) centers on a high-stakes standoff with the U.S. government and the discovery of unprecedented cybersecurity risks.

Here are the primary pillars of the current controversy:

1. The Pentagon Standoff & Federal Ban

In February 2026, the Trump administration ordered all federal agencies to stop using Claude. This followed a public clash where Anthropic CEO Dario Amodei refused to remove "safety guardrails" that prevent Claude from being used for mass domestic surveillance and fully autonomous weapons systems.

• The Conflict: The Department of Defense (DoD) demanded "unrestricted use" for all lawful military purposes. Anthropic argued this would allow safeguards to be "disregarded at will."

• The Retaliation: The DoD designated Anthropic a "supply chain risk"—a label usually reserved for foreign adversaries like Huawei—effectively barring many private contractors from using the tool.

• The Irony: Reports surfaced in March 2026 that despite the ban, the military allegedly used Claude's capabilities to coordinate specific airstrikes in the Middle East, leading to accusations of hypocrisy and a pending federal injunction.

2. "Claude Mythos" and the "Too Dangerous to Release" Debate

In April 2026, Anthropic announced its most powerful model to date, Claude Mythos, but simultaneously declared they would not release it to the public.

• The Risk: Anthropic claims Mythos can identify and exploit thousands of "zero-day" vulnerabilities in every major operating system and web browser.

• The Controversy: Critics are split. Some praise the "Responsible Scaling Policy," while others—including some cybersecurity experts—accuse Anthropic of using "safety" as a marketing stunt to build hype or to justify exclusive, high-priced contracts with a select few tech giants (Project Glasswing).

3. The "Constitutional AI" Friction

Claude's internal "Constitution" (a set of ethical rules it follows during training) has grown from 2,700 words to over 23,000 words.

• User Complaints: Many power users complain that Claude is "too careful" or "moralizing." It frequently refuses tasks that it deems could indirectly lead to harm, which some professionals find frustratingly pedantic compared to rivals like OpenAI’s models.

• Hallucination vs. Refusal: Unlike other models that might "hallucinate" (make things up) to be helpful, Claude is programmed to prioritize safety and uncertainty, leading to a high "refusal rate" that remains a point of contention in the developer community.

4. Data Breaches and "Claude Code"

The release of Claude Code (an agentic tool that can write and execute code autonomously) has been linked to significant security incidents.

• The Mexico Breach: Between late 2025 and early 2026, a threat actor allegedly used a jailbroken version of Claude Code to breach ten Mexican government agencies, exposing nearly 195 million identities. This has fueled the argument that Anthropic's tools are "dual-use" weapons that are becoming too powerful to control.

---

Summary of the "Vibe": Anthropic is currently positioned as the "principled rebel" of Silicon Valley—willing to lose billions in government contracts to maintain its ethical red lines, while simultaneously being criticized for creating a tool so powerful that it may be too dangerous for general public access.

------------------------------

Source

Google Gemini 

Mundane Astrology for April of 2026

Mundane Astrology for April of 2026

--------------------------------------

For the month of April 2026, the stellium in Aries—comprising Mercury, Mars, Saturn, and Neptune—is a highly potent and complex configuration. In mundane astrology, Aries represents the "Aries Point" (0 degrees), a degree of world prominence where internal shifts manifest as collective, visible events.

Having both Saturn (structure, restriction) and Neptune (dissolution, vision) conjunct at the start of Aries is the defining "New Era" signature of 2026. Adding the inner planets, Mercury and Mars, acts as the "trigger" for this slow-moving conjunction.

1. The Mars Factor: The Engine Ignites

Mars enters its home sign of Aries on April 9, where it is exceptionally strong (Dignified). In mundane terms, a strong Mars in Aries usually signals a surge in military activity, industrial breakthroughs, or grassroots uprisings.

• Mars conjunct Saturn/Neptune: Around mid-April, Mars passes over the Saturn-Neptune conjunction. This is a classic "stop-and-go" energy. Saturn acts as the brakes, while Mars is the accelerator. On a global scale, this can manifest as redirected aggression or "structured activism"—where long-standing grievances (Neptune) are finally organized into disciplined action (Saturn/Mars).

2. Mercury in Aries: The Command Center

Mercury enters Aries on April 14, joining the group.

• Direct Communication: Expect a shift from the "foggy" or secretive communications of the previous month (when Mercury was in Pisces) to blunt, decisive, and potentially inflammatory rhetoric.

• The "Fog" Trigger: In the first few days of this transit, Mercury conjoins Neptune and Saturn. This is a critical period for "clarifying the unsaid." Hidden documents or systemic failures (Neptune/Saturn) may be brought to light through sudden, sharp reporting (Mercury/Mars).

3. The Saturn-Neptune Dynamic: "Materializing the Dream"

The conjunction of Saturn and Neptune at 0 degrees Aries is a rare 36-year cycle.

• Dissolution of Old Borders: Neptune dissolves what Saturn builds. In Aries, this suggests the literal dissolving of old national boundaries or the restructuring of leadership models that have become obsolete.

• The "Socialist" or "Utopian" Impulse: Historically, Saturn-Neptune cycles are associated with the rise of social safety nets or, conversely, the collapse of grand illusions in government. With this occurring in Aries, the "pioneer" sign, we are likely seeing the first practical steps toward a "New Earth" infrastructure—moving from purely theoretical (Pisces) to the first spark of implementation (Aries).

4. Key Mundane Indicators for April

Planet	Role in the Stellium	Mundane Manifestation
Mars	The Trigger / Energy	Increased "heat" in geopolitics; push for autonomy.
Saturn	The Architect / Reality	New regulations; austerity measures; building new foundations.
Neptune	The Visionary / Dissolver	Scandals involving liquid assets, chemicals, or ideological "fogs."
Mercury	The Messenger	Rapid-fire news cycles; decisive legislative moves.

Summary for the Month

The mid-month period (specifically around the New Moon in Aries on April 17) will likely be the peak of this stellium's power. It marks a "point of no return" for many collective projects initiated in early 2026. While the presence of Saturn and Neptune creates a backdrop of uncertainty and restructuring, the arrival of Mars and Mercury provides the necessary "fuel" to force these issues into the public eye.

-------------------------------

The Uranus ingress into Gemini on April 25, 2026, acts as the "lightning strike" that grounds the volatile energy of the Aries stellium. While the planets in Aries provide the raw, explosive force and the structural collapse of old systems, Uranus in Gemini provides the new medium through which that energy will be expressed for the next seven years.

Here is how the two configurations tie together:

1. From "Action" to "Idea" (Aries to Gemini)

The Aries stellium (Mercury, Mars, Saturn, Neptune) is a Cardinal, high-heat signature. It represents a "push to the brink" in terms of physical action, military tension, and systemic stress.

• The Transition: As Uranus enters Gemini just as the inner planets (Mercury and Mars) are still "triggering" the Saturn-Neptune conjunction, we see a shift from physical confrontation to informational warfare and technological revolution. * Mundane Link: The "Aries fire" of the stellium may manifest as a literal crisis (energy, borders, or leadership), but the Uranus ingress suggests the solution or the disruption will come through a radical leap in communication, AI, or decentralized networks.

2. The Mercury Connection: The "Double Trigger"

Mercury is the ruler of Gemini. On April 25, Mercury is still in Aries, part of that potent stellium.

• Mutual Influence: Because the ruler of the Ingress (Mercury) is currently entangled with Saturn and Neptune, the "New Era" of Uranus in Gemini begins under a heavy cloud of regulation (Saturn) and ideological confusion (Neptune).

• The Result: The first phase of Uranus in Gemini (April–May) will likely involve massive, sudden legislative attempts to "reign in" the internet, AI, or free speech, driven by the intense, reactive energy of the Aries planets.

3. Historical Precedents: The "War of Information"

Historically, Uranus in Gemini is associated with periods of intense domestic and international conflict where innovation changes the outcome (e.g., the US Revolutionary War, the Civil War, and WWII).

• The 2026 Twist: In those previous cycles, we didn't have the 0° Aries Saturn-Neptune conjunction occurring simultaneously.

• Synthesis: This suggests that while the Aries stellium may push the world toward the "edge" of traditional conflict, the Uranus ingress indicates the conflict will be fought through drones, cyber-attacks, and narrative control. It is the "digitization" of the Mars/Saturn friction.

4. Technical Integration (Midpoints & Aspects)

For your technical analysis, keep an eye on the following:

• Uranus at 0° Gemini: This is 60 degrees (Sextile) to the Saturn-Neptune conjunction at 0 degrees Aries. This is a highly supportive, fast-moving aspect. It suggests that the "dissolving" of old structures (Saturn/Neptune) will be rapidly replaced by "Uranian" alternatives (new tech, new transport, new ways of thinking).

• The Ingress Chart: Look for the Mercury/Uranus midpoint on the day of the ingress. Since Mercury is in the Aries stellium, this midpoint becomes a "live wire" for sudden, shocking announcements that redefine the global financial or political landscape.

Summary of the Relationship

Configuration	Function	Nature
Aries Stellium	The "Breaking Point"	Destructive, Urgent, Structural
Uranus in Gemini	The "New Blueprint"	Rapid, Electric, Informational

The Bottom Line: The Aries planets "clear the ground" by causing a crisis in leadership and traditional systems, while the Uranus ingress on April 25 ensures that the recovery won't be a return to the past, but a leap into a hyper-accelerated, tech-driven future.

----------------------------------

The Mars-Uranus square (which peaked in late February and early March 2026) acted as the "detonator" for the much larger Saturn-Neptune conjunction (0 degrees Aries).

In mundane astrology, when a fast-moving square from a planet like Mars hits an outer planet (Uranus) just as a major new cycle is beginning (Saturn-Neptune), it creates a "violent birth" for the new era.

Here is how these two distinct signatures are currently weaving together:

1. The Shock to the System (The Square)

The Mars-Uranus square at the end of the previous month brought sudden, disruptive volatility. In mundane terms, this typically correlates with:

• Infrastructure Shocks: Cyber-attacks, electrical grid instability, or sudden aviation/technological failures.

• Market Spasms: "Flash crashes" or sudden regulatory pivots that catch investors off guard.

• Social Friction: Spontaneous protests or "leaderless" movements that arise overnight.

This square ensured that the Saturn-Neptune era didn't start quietly. It provided a "jolt" that broke the old Piscean fog and forced the collective into the raw, urgent reality of Aries.

2. The Dissolving of the Old Guard (The Conjunction)

While Mars and Uranus were providing the "shocks," Saturn and Neptune at 0 degrees Aries were (and still are) performing a much deeper operation: The dissolution of established authority.

• The "Leak" Factor: Saturn (boundaries) being dissolved by Neptune (the ocean) often manifests as the "leaking" of secrets that compromise those in power.

• Institutional Collapse: We are seeing the "erosion of the rock." Systems we thought were permanent—certain financial structures, government agencies, or even healthcare models—are proving to be "hollow" or based on illusions that can no longer be sustained under the heat of Aries.

3. How the April Stellium "Settles the Score"

The stellium (Mercury, Mars, Saturn, Neptune) is the direct fallout of that earlier Mars-Uranus tension.

• From Reaction to Strategy: The Mars-Uranus square was reactive and chaotic. Now that Mars has moved into the Aries stellium and is joining Saturn, that chaotic energy is being harnessed and structured. * The "Cleanup" Operation: If the Mars-Uranus square "blew the doors off," the current stellium is about the new occupants moving in. Mercury’s presence here means the "narrative" of the crisis is finally being written—though with Neptune involved, expect the "official story" to be highly curated or even deceptive.

4. Synthesis for the DIY Investor

If you are looking at the 2026–2028 framework for infrastructure or industrial companies, this sequence is vital:

1. The Mars-Uranus Square: Likely highlighted the weakest links in supply chains or technological dependencies (The "Crisis").

2. The Saturn-Neptune Conjunction: Is currently forcing a revaluation of intrinsic value—assets that were "vapor" (Neptune) are being marked to reality (Saturn).

3. The April Stellium: Represents the re-mobilization. Companies that survive the "shocks" of the previous month will now be the ones building the new, hardened infrastructure required for the Uranus in Gemini era.

In short: The previous month was the "breaking point." This month is the "starting point." You are seeing the shift from unpredictable disruption (Uranus) to disciplined, albeit visionary, reconstruction (Saturn-Neptune-Mars).

---------------------------------

Source

Google Gemini

The Last Lesson My Mother Taught Me

The Last Lesson My Mother Taught Me

Joseph Varon   March 27, 2026   Philosophy, Public Health, Technology  

The sounds in my mother’s room during her final days stood in stark contrast to those that have defined most of my professional experience. There were no ventilator alarms piercing the air every few minutes, no overhead announcements echoing down hospital corridors, no infusion pumps demanding attention in the middle of the night. There were no teams rushing through doors, pushing carts full of medications, no physicians frantically adjusting machines that were temporarily holding physiology together, no organized chaos that defines the modern intensive care unit. Instead, there was quiet.

For decades in intensive care units, where noise signifies action and action equates to survival, quietness has felt unsettling. Intensive care medicine depends on urgency, real-time monitoring, and rapid decision-making to prevent death. I have lived my professional life in that environment. But in that room, I was not the physician. I was a son. And now, as I write this, I am a son whose mother has died.

My mother did not die in an intensive care unit. She was not surrounded by machines, alarms, or artificial light. She died at home, in a room imbued with the quiet weight of memory. Decades of life were embedded in those walls, which had witnessed birthdays, conversations, laughter, arguments, and the countless ordinary moments that, in retrospect, constitute the true foundation of a life. A peripherally inserted central catheter (PICC) line rested in her arm, serving not as a symbol of escalation but as an instrument of compassion. Medications were given to relieve discomfort rather than to reverse disease. Nurses entered the room with calm, deliberate purpose rather than urgency. Their voices were soft, their movements measured. Their objective was not to save her life, but to honor it. There was no battle being fought. There was acceptance. And in that acceptance, there was dignity.

Around her, the people who loved her most gathered. Children. Grandchildren. Family members who had traveled from different places, not in panic, but in recognition that this moment, this final chapter, was one that mattered deeply.

Sometimes we spoke. Sometimes we sat in silence. Sometimes we simply held her hand.

There is a form of communication in those moments that medicine cannot teach or measure. It is neither physiological nor quantifiable, yet it is real.

Meanwhile, my phone would not stop. Dozens of calls. Hundreds of text messages. Colleagues from across the country. Students from years past. Friends, patients, acquaintances. All reaching out with genuine compassion. And almost every message carried the same underlying sentiment: “We are praying she improves.” “We hope she pulls through.” “Let us know what else can be done.” I understood the intention behind every one of those messages. They were kind. They were sincere. They were deeply human. But they were also revealing.

Because what they reflected, collectively and unconsciously, was something we rarely acknowledge openly: We have become a culture that no longer knows how to accept death.

Over the past century, medicine has achieved extraordinary success. We have extended life expectancy, eradicated diseases, developed technologies that can temporarily replace failing organs, and established systems capable of sustaining biological function long after the body can no longer do so independently.

Ventilators can breathe for failing lungs. Dialysis machines can replace kidney function. Vasopressors can maintain blood pressure when the cardiovascular system collapses. Extracorporeal support can oxygenate blood outside the body. Artificial nutrition can sustain metabolism indefinitely. 

These are remarkable achievements. However, these advancements have also fostered a dangerous illusion: the belief that death is optional, and that with sufficient intervention, escalation, and technological force, the inevitable can be indefinitely postponed. We cannot.

Every experienced physician knows this. Not intellectually, but experientially. We have seen it. We have lived it. We have stood at the bedside when the machines are running, the medications are maximized, the monitors are active, and yet the patient is still dying.

There comes a moment when biology cannot be negotiated with. And when that moment arrives, the question changes. It must change. The question is no longer: How do we keep this patient alive? The question becomes: How do we allow this patient to die without suffering?

This is where modern medicine, despite its many strengths, often falls short. The failure is not due to insufficient knowledge, but rather a lack of cultural and institutional willingness to adapt. Comfort care has been mischaracterized, misunderstood, and in many cases, quietly stigmatized. Families are often led—explicitly or implicitly—to believe that choosing comfort care means “giving up,” that it represents abandonment, or worse, that it reflects a lack of love or commitment. Nothing could be further from the truth.

Comfort care is not the absence of medicine. It is the most honest application of medicine. It is the moment when we stop assuming that technology can reverse the irreversible, and instead use our knowledge, skill, and compassion to reduce suffering, preserve dignity, and support both the patient and the family through the most profound transition in human existence. In many ways, it is the highest form of care we can provide. And yet, despite this, we have built a system that often resists it.

Modern healthcare systems, particularly in the United States, are not neutral in these decisions. They are structured, incentivized, and organized to favor intervention over reflection, escalation over restraint, and procedure over presence. There are financial incentives associated with intensive care unit, procedures, and prolonged hospitalization. Institutional pressures often encourage clinicians to “do everything,” even when such actions no longer serve the patient. There is also legal fear: fear of being accused of insufficient intervention, fear of litigation, and fear of retrospective judgment. And there is something even more pervasive: A cultural refusal to acknowledge that death is not a medical error.

We have, in many ways, medicalized death to such an extent that we have stripped it of its humanity. We have transformed the final chapter of life into a technical problem to be solved, rather than a human experience to be understood. We measure oxygen saturation, blood pressure, and heart rate variability. We adjust ventilator settings. We titrate medications. We track and react to lab values. But we rarely ask the most important question: What does this person want? It is not what we can do, but what we should do.

Standing beside my mother in those final days, I reflected on the thousands of conversations I have had with families in intensive care units. I have explained mechanical ventilation, described dialysis, outlined survival probabilities, and guided families through decisions that carry immense emotional weight. But what I now understand more deeply than ever is this: The hardest part of those conversations is not medical. It is existential.

Families are not just confronting the decline of a loved one. They are confronting the limits of control. The limits of medicine. The limits of life itself.

In a culture that has spent decades reinforcing the idea that everything is fixable, that every problem has a solution, and that every decline can be reversed, this confrontation becomes almost unbearable.

At home, the experience was different. There were no alarms. No overhead pages. No artificial urgency. The pace slowed. The noise disappeared. And in that quiet, something essential emerged. Clarity.

There was time to remember. Time to speak. Time to sit in silence without feeling that something needed to be done. Presence became the primary form of care.

Holding a hand became more meaningful than adjusting a machine. A whispered word carried more weight than another intervention. The absence of chaos allowed something deeply human to take its place. We do not teach this in medical school. But we should.

My mother’s passing reinforced a lesson that extends far beyond medicine and into every household, every family, every individual. End-of-life conversations are not optional.

They are essential. They are not conversations to be avoided, postponed, or delegated to “later.” Because later, in medicine, it often arrives suddenly, and without warning.

What do you want when your body begins to fail? Not in abstraction. Not in theory. But in reality. Do you want aggressive life support if recovery is unlikely? Do you want prolonged mechanical ventilation, invasive procedures, extended hospitalization, if the outcome is survival without quality, without independence, without dignity? Or do you want comfort? Familiar surroundings? The presence of those you love? A peaceful transition rather than a prolonged struggle? There is no universal right answer. But there is a universal mistake: Not asking the question at all.

When these conversations do not happen, families are left to guess. And in that space of uncertainty, decisions become heavily burdened by guilt, fear, doubt, and the haunting question of whether they are doing the right thing. I have seen families fracture under that weight.

I have seen individuals carry that burden for years. And all of it could have been alleviated by a conversation that never took place. Advance directives, living wills, open discussions. These are not bureaucratic exercises. They are acts of love. They are gifts we give to those who will one day have to speak on our behalf.

Medicine today stands at a crossroads. We possess unprecedented technological capability and can extend biological life in ways that were once unimaginable. However, we have not developed an equally sophisticated cultural framework to guide how and when to use this power. We have confused capability with obligation. Just because we can do something does not mean we should. And yet, increasingly, our systems behave as if intervention is the default, and restraint requires justification. That inversion is dangerous.

My mother’s final days, and her passing, brought that reality into sharp focus.

There was no chaos. No unnecessary suffering. No prolonged medicalization of a process that, at its core, is deeply human. There was dignity. There was peace. There was acceptance.

And in that environment, I was reminded of something that medicine must never forget:

Our role is not only to extend life. It is to honor it.

We fight when fighting makes sense. We intervene when recovery is possible. We deploy every tool we have when there is a reasonable chance of restoring meaningful life. But when that chance disappears, wisdom must replace reflex. At that moment, the role of medicine does not end. It transforms. It becomes quieter. More deliberate. More human. And, perhaps, more important than ever.

My mother’s final lesson was not spoken. It was lived. It was in the stillness of the room. In the presence of family. In the absence of unnecessary intervention. In the quiet dignity of a life reaching its natural conclusion. She taught me that death is not the enemy. Suffering is.

She taught me that acceptance is not surrender. It is understanding. She reminded me that the measure of medicine lies not only in how long we can prolong life, but also in how well we can guide its final moments. 

In the end, we cannot stop the circle of life. But we can decide how we meet its final turn. With fear or with clarity. With chaos or with dignity. With denial or with truth. My mother chose dignity. In doing so, she imparted one final lesson, which I will carry into every intensive care unit, every patient encounter, and every difficult conversation. Not how to fight death. But how to respect it.

----------------------------

Joseph Varon, MD, is a critical care physician, professor, and President of the Independent Medical Alliance. He has authored over 980 peer-reviewed publications and serves as Editor-in-Chief of the Journal of Independent Medicine.

------------------------------

Source

https://brownstone.org/articles/the-last-lesson-my-mother-taught-me/